[HTML][HTML] Epidermal growth factor receptor mutations in resectable non-small cell lung cancer patients and their potential role in the immune landscape
W Xia, W Mao, R Chen, R Lu, F Liu, Y He… - … Medical Journal of …, 2019 - ncbi.nlm.nih.gov
W Xia, W Mao, R Chen, R Lu, F Liu, Y He, S Wang, X Li, M Zheng
Medical Science Monitor: International Medical Journal of Experimental …, 2019•ncbi.nlm.nih.govBackground The epidermal growth factor receptor (EGFR) is a therapeutic target for non-
small cell lung cancer (NSCLC), but knowledge on gene mutations that contribute to NSCLC
development and persistence is lacking. In this study, we investigated genetic variations in
EGFR and their association with the clinical and pathological factors of NSCLC.
small cell lung cancer (NSCLC), but knowledge on gene mutations that contribute to NSCLC
development and persistence is lacking. In this study, we investigated genetic variations in
EGFR and their association with the clinical and pathological factors of NSCLC.
Abstract
Background
The epidermal growth factor receptor (EGFR) is a therapeutic target for non-small cell lung cancer (NSCLC), but knowledge on gene mutations that contribute to NSCLC development and persistence is lacking. In this study, we investigated genetic variations in EGFR and their association with the clinical and pathological factors of NSCLC.
ncbi.nlm.nih.gov